The aim of the work was an assessment of the morphological structure and chemical composition of dental hard tissues in persons suffering from chronic kidney disease and the effectiveness of remineralizing therapy in them. The study of the morphological structure and chemical composition of dental hard tissues in individuals suffering from chronic kidney disease and the effectiveness of 6 weeks of remineralizing therapy in the course of individual oral hygiene in combination with the intake of vitamin-mineral complex was conducted by means of ABT-55 electron microscope (Japan) combined with a LinkAN-10 000/S85 microprobe (United Kingdom) in comparison with persons without somatic pathology. It has been established that in people suffering from chronic kidney disease dental hard tissues morphological features were determined by their pathological changes due to carious process or non-carious lesions. In chronic kidney disease a significant decrease in the level of mineralization in both enamel and dentin was found, which was most pronounced in patients with chronic renal failure and did not depend on whether they received hemodialysis. The use of remineralizing therapy in people with chronic kidney disease within the framework of individual oral hygiene combined with a vitamin-mineral complex intake for 6 weeks significantly contributed to an increase in the Ca/P ratio in tooth enamel and may be seen as a useful tool for prevention of dental hard tissues pathology in the patient's group.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.17116/stomat20199803125 | DOI Listing |
Sports Med Open
January 2025
Institute of Primary Care, University of Zurich, Zurich, Switzerland.
Background: Marathon training and running have many beneficial effects on human health and physical fitness; however, they also pose risks. To date, no comprehensive review regarding both the benefits and risks of marathon running on different organ systems has been published.
Main Body: The aim of this review was to provide a comprehensive review of the benefits and risks of marathon training and racing on different organ systems.
Clin Exp Nephrol
January 2025
Reach-J Steering Committee, Tsukuba, Ibaraki, Japan.
Background: Although several studies have examined the Kidney Disease Quality of Life (KDQOL) in patients with chronic kidney disease (CKD), the factors associated with kidney-related symptoms have not been fully explored.
Methods: This nationwide multicenter cohort study enrolled 2248 patients. To identify the factors associated with each item or the three KDQOL domains, such as burden of kidney disease, symptoms/problems of kidney disease, and impact of kidney disease on daily life, multiple regression analysis was performed using baseline data.
Int J Cardiovasc Imaging
January 2025
Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.
The use of conventional contrast agents in computed tomography (CT) and magnetic resonance (MR) imaging is often limited in patients with chronic kidney disease (CKD) due to potential nephrotoxicity. Ferumoxytol, originally developed for iron supplementation, has emerged as a promising alternative MR contrast agent that is safer for patients with CKD. This study aims to present our center's experience with ferumoxytol as a contrast agent in CKD patients.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, No.2, Xihuan South Road, Beijing Economic and Technological Development Zone, Daxing District, Beijing, China.
Spirometry findings, such as restrictive spirometry and airflow obstruction, are associated with renal outcomes. Effects of spirometry findings such as preserved ratio impaired spirometry (PRISm) and its trajectories on renal outcomes are unclear. This study aimed to investigate the impact of baseline and trajectories of spirometry findings on future chronic kidney disease (CKD) events.
View Article and Find Full Text PDFSci Rep
January 2025
Renal Division, Department of Medicine, Universidade Federal de São Paulo, Rua Pedro de Toledo, 781, São Paulo, SP, 04039-032, Brazil.
Partial stenosis of the renal artery causes renovascular hypertension (RVH) and is accompanied by chronic renal ischemia, resulting in irreversible kidney damage. Revascularization constitutes the most efficient therapy for normalizing blood pressure (BP) and has significant benefits for renal function; however, the tissue damage caused by chronic hypoxia is not fully reversed. Mesenchymal stem cells (MSCs) have produced discrete results in minimizing RVH and renal tissue and functional improvements since the obstruction persists.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!